Clinical utility of a novel coronary heart disease risk-assessment test to further classify intermediate-risk patients

Clinical Cardiology

Volumn 36, Issue 10, 2013, Pages 621-627

  Solomon, Matthew D ^a   Tirupsur, Ahalya ^b   Hytopoulos, Evangelos ^b   Beggs, Michael ^b   Harrington, Douglas S ^b,c   French, Cynthia ^b   Quertermous, Thomas ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Aviir Inc   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ARTICLE; CARDIOLOGY; CLINICAL DECISION MAKING; COMORBIDITY; DISEASE MARKER; GENERAL PRACTICE; GYNECOLOGY; HEALTH SURVEY; HUMAN; INTERNAL MEDICINE; ISCHEMIC HEART DISEASE; LABORATORY TEST; LIPID BLOOD LEVEL; OBSTETRICS; PHYSICAL EXAMINATION; PHYSICIAN; PRACTICE GUIDELINE; RISK ASSESSMENT;

ADULT; AGED; BIOLOGICAL MARKERS; COMORBIDITY; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DECISION SUPPORT TECHNIQUES; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS;

EID: 84885473966     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22185     Document Type: Article

References (22)

1. Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010; 56: 2182-2199.
2. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97: 1837-1847.
3. Lim LS, Haq N, Mahmood S, et al. Atherosclerotic cardiovascular disease screening in adults: American College of Preventive Medicine position statement on preventive practice. Am J Prev Med. 2011; 40: 381. e1-381.e10.
4. Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003; 290: 898-904.
5. Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005; 111: 499-510.
6. Schmieder RE, Goebel M, Bramlage P,. Barriers to cardiovascular risk prevention and management in Germany-an analysis of the EURIKA study. Vasc Health Risk Manag. 2012; 8: 177-186.
7. Montgomery AA, Fahey T, MacKintosh C, et al. Estimation of cardiovascular risk in hypertensive patients in primary care. Br J Gen Pract. 2000; 50: 127-128.
8. Ford ES, Giles WH, Mokdad AH,. The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol. 2004; 43: 1791-1796.
9. Cross DS, McCarty CA, Hytopoulos E, et al. Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts. Curr Med Res Opin. 2012; 28: 1819-1830.
10. McCarty CA, Wilke RA, Giampietro PF, et al. Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank. Personalized Med. 2005; 2: 49-79.
11. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004; 110: 227-239.
12. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
13. Eaton CB, Galliher JM, McBride PE, et al. Family physicians' knowledge, beliefs, and self-reported practice patterns regarding hyperlipidemia: a National Research Network (NRN) survey. J Am Board Fam Med. 2006; 19: 46-53.
14. Yeboah J, McClelland RL, Polonsky TS, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012; 308: 788-795.
15. Farley TA, Dalal MA, Mostashari F, et al. Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Prev Med. 2010; 38: 600-609.
16. Ma J, Sehgal NL, Ayanian JZ, et al. National trends in statin use by coronary heart disease risk category. PLoS Med. 2005; 2: e123.
17. Greenland P., Should the resting electrocardiogram be ordered as a routine risk assessment test in healthy asymptomatic adults? JAMA. 2012; 307: 1530-1531.
18. Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011; 124: 2458-2473.
19. Muntner P, Mann D, Wildman RP, et al. Projected impact of polypill use among US adults: medication use, cardiovascular risk reduction, and side effects. Am Heart J. 2011; 161: 719-725.
20. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011; 123: 933-944.
21. Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction. Circulation. 2010; 121: 586-613.
22. Wyman RA, Gimelli G, McBride PE, et al. Does detection of carotid plaque affect physician behavior or motivate patients? Am Heart J. 2007; 154: 1072-1077.